NeuExcell Therapeutics

0 followers


NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. They have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.

Industries

Employees

11-50

Links

Org chart

CEOs

Collapse
Jie Xu
Co-Founder & Head of Discovery
Josephine Yang
CFO, China
J. David Jacobs
General Counsel & SVP
Russ Addis
VP, Research, US
Yuchen Chen
VP, R&D, China
Kun (Quinn) Yao
Vice President (VP), Head of CMC and Tech Ops
Kai Zhou
Director
Egor Zhelezniak
Head Of HR (director)
Tsang-Chih Kuo
Director, CMC Department